LARRAITZ EGAÑA OTAÑO-rekin lankidetzan egindako argitalpenak (9)
2022
2021
-
Identification of a dexamethasone mediated radioprotection mechanism reveals new therapeutic vulnerabilities in glioblastoma
Cancers, Vol. 13, Núm. 2, pp. 1-23
2020
-
Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital
Scientific Reports, Vol. 10, Núm. 1
2019
-
Liquid biopsy in glioblastoma: Opportunities, applications and challenges
Cancers, Vol. 11, Núm. 7
2018
-
Indirect costs associated with glioblastoma: Experience at one hospital
Neurologia, Vol. 33, Núm. 2, pp. 121-128
-
PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
Scientific Reports, Vol. 8, Núm. 1
2017
-
Oncogenic activity of SOX1 in glioblastoma
Scientific Reports, Vol. 7
2016
-
SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin
Scientific Reports, Vol. 6
-
Targeting SOX2 as a therapeutic strategy in glioblastoma
Frontiers in Oncology